G

Galux

22 employees

Galux provides molecular design technology focusing on discovering and developing novel drugs for incurable and rare diseases.

Basic info

Industry

biotechnology research

Sectors

Antibody Drug
Biotechnology
Enzyme Drug
Product Research
Artificial Intelligence
Chemical Drug
Large Molecule Drug
Machine Learning
Drug Discovery
Protein Drug
Biological Drug
Professional Services
Small Molecule Drug
Neural Network
Drug Design
Medical
Drug Development

Date founded

2020

Funding rounds raised

Total raised

$4M

from 2 investors over 2 rounds

G

Galux raised $4M on December 16, 2021

Investors: DAYLI Partners and 카카오브레인 - Kakao Brain

FAQ